Showing results (1051-1060 of 6,501) with videos related to
Sort By:
Pageof 651
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Stimulation of non-specific resistance to tumors in the mouse using a poly(maleic-acid-styrene)-conjugated neocarzinostatinF Suzuki, R B Pollard, H MaedaCancer Immunology, Immunotherapy : CII|October 1, 2016
Phase I/II trial of combination of temozolomide chemotherapy and immunotherapy with fusions of dendritic and glioma cells in patients with glioblastomaYasuharu Akasaki, Tetsuro Kikuchi, Sadamu Homma, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1988
Characterisation of suppressor cells generated following cryosurgery of an HSV-2-induced fibrosarcomaM G Wing, K Rogers, G Jacob, et al.Cancer Immunology, Immunotherapy : CII|June 14, 2012
Using the allergic immune system to target cancer: activity of IgE antibodies specific for human CD20 and MUC1Pearline Zhaoying Teo, Paul J Utz, Joseph A MollickCancer Immunology, Immunotherapy : CII|September 26, 2014
Novel N-amidinopiperidine-based proteasome inhibitor preserves dendritic cell functionality and rescues their Th1-polarizing capacity in Ramos-conditioned tumor environmentUrban Švajger, Martina Gobec, Aleš Obreza, et al.Cancer Immunology, Immunotherapy : CII|September 29, 2014
Randomized controlled phase III trial of adjuvant chemo-immunotherapy with activated killer T cells and dendritic cells in patients with resected primary lung cancerHideki Kimura, Yukiko Matsui, Aki Ishikawa, et al.Cancer Immunology, Immunotherapy : CII|October 8, 2014
Elotuzumab enhances natural killer cell activation and myeloma cell killing through interleukin-2 and TNF-α pathwaysBalaji Balasa, Rui Yun, Nicole A Belmar, et al.Cancer Immunology, Immunotherapy : CII|October 18, 2014
Dynamics of the IL-33/ST2 network in the progression of human colorectal adenoma to sporadic colorectal cancerGuanglin Cui, Haili Qi, Mona D Gundersen, et al.Cancer Immunology, Immunotherapy : CII|September 18, 2014
Successful treatment with Ipilimumab and Interleukin-2 in two patients with metastatic melanoma and systemic autoimmune diseaseMagnus Pedersen, Rikke Andersen, Peter Nørgaard, et al.Cancer Immunology, Immunotherapy : CII|August 8, 2014
Achievements and challenges of adoptive T cell therapy with tumor-infiltrating or blood-derived lymphocytes for metastatic melanoma: what is needed to achieve standard of care?Inge Marie Svane, Els M VerdegaalPageof 651